E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/20/2005 in the Prospect News Biotech Daily.

Serono reiterated by Merrill Lynch at buy

Serono SA was reiterated by Merrill Lynch analyst Erica Whittaker at a buy rating with a price target of CHF 930 per share, or $19.60, following second-quarter earnings that showed better-than-expected top line growth and gross margin. Serono shares Wednesday on the VTX jumped $24.50, or 2.91%, to $867.00 on volume of 188,428 shares versus the three-month running average of 41,159.2 shares, and on the NYSE gained $0.96, or 5.94%, to $17.13 on volume of 355,500 shares versus the three-month running average of 126,485 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.